Literature DB >> 2008910

Citrate and renal calculi: new insights and future directions.

C Y Pak1.   

Abstract

Citrate is pathogenetically important in stone formation, because it retards the crystallization of stone-forming calcium salts and because its level in urine is low in many patients with nephrolithiasis. Potassium citrate is useful therapeutically, because it can often restore normal urinary citrate. Hypocitraturia often results from dietary aberrations, including sodium excess, and exaggerated intake of animal proteins. Hypocitraturia is frequently accompanied by a low net gastrointestinal absorption of alkali. New drugs are under development as improvements or refinements of currently available potassium citrate. They are potassium citrate 10-mEq-tablet preparation, effervescent calcium citrate, and potassium-magnesium citrate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008910     DOI: 10.1016/s0272-6386(12)80635-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  21 in total

Review 1.  [Alkaline citrates in urology. A status report].

Authors:  L Rinnab; R E Hautmann; M Straub
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

Review 2.  [Prevention of nephrolithiasis. Established strategies and new concepts].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

Review 3.  [Evidence-based pharmacological metaphylaxis of stone disease].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

4.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

Review 5.  Acid-base metabolism: implications for kidney stones formation.

Authors:  Bernhard Hess
Journal:  Urol Res       Date:  2006-01-13

6.  Growth inhibition of Struvite crystals in the presence of juice of Citrus medica Linn.

Authors:  C K Chauhan; M J Joshi
Journal:  Urol Res       Date:  2008-09-16

7.  Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Marcelo Ferraz Oliveira Souto; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

8.  Renal stone clinic survey: calcium stone formers' self-declared understanding of and adherence to physician's recommendations.

Authors:  Bernhard Hess
Journal:  Urolithiasis       Date:  2016-08-29       Impact factor: 3.436

9.  Effect of potassium depletion on urinary stone risk factors in Wistar rats.

Authors:  Chatchai Yachantha; Rayhan Zubair Hossain; Kenichi Yamakawa; Kimio Sugaya; Piyaratana Tosukhowong; Yoshihide Ogawa; Seiichi Saito
Journal:  Urol Res       Date:  2009-10-16

10.  The effects of citrate and urine on calcium oxalate crystal aggregation.

Authors:  H G Tiselius; A M Fornander; M A Nilsson
Journal:  Urol Res       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.